Type II-C CRISPR-Cas9 Biology, Mechanism, and Application
- PMID: 29202216
- PMCID: PMC5815938
- DOI: 10.1021/acschembio.7b00855
Type II-C CRISPR-Cas9 Biology, Mechanism, and Application
Abstract
Genome editing technologies have been revolutionized by the discovery of prokaryotic RNA-guided defense system called CRISPR-Cas. Cas9, a single effector protein found in type II CRISPR systems, has been at the heart of this genome editing revolution. Nearly half of the Cas9s discovered so far belong to the type II-C subtype but have not been explored extensively. Type II-C CRISPR-Cas systems are the simplest of the type II systems, employing only three Cas proteins. Cas9s are central players in type II-C systems since they function in multiple steps of the CRISPR pathway, including adaptation and interference. Type II-C CRISPR systems are found in bacteria and archaea from very diverse environments, resulting in Cas9s with unique and potentially useful properties. Certain type II-C Cas9s possess unusually long PAMs, function in unique conditions (e.g., elevated temperature), and tend to be smaller in size. Here, we review the biology, mechanism, and applications of the type II-C CRISPR systems with particular emphasis on their Cas9s.
Conflict of interest statement
The authors declare the following competing financial interest(s): E.J.S. is a co-founder and scientific advisor of Intellia Therapeutics. Northwestern University and the University of Massachusetts Medical School have patents pending for CRISPR technologies of which E.J.S. is an inventor.
Figures


References
-
- Marraffini LA. CRISPR-Cas immunity in prokaryotes. Nature. 2015;526:55–61. - PubMed
-
- Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin EV, van der Oost J. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science. 2016;353:aad5147. - PubMed
-
- Barrangou R, Doudna JA. Applications of CRISPR technologies in research and beyond. Nature biotechnology. 2016;34:933–941. - PubMed